Cargando…

Intravenous immunoglobulin therapy could have efficacy in severe sepsis

Detalles Bibliográficos
Autores principales:	Kim, Ahmin, Yokota, Mari, Saito, Noriko, Takeda, Munekazu, Harada, Tomoyuki, Namiki, Mizuho, Yaguchi, Arino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952215/ http://dx.doi.org/10.1186/cc12939

Ejemplares similares

Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013)

Polymyxin B-direct hemoperfusion therapy improves mean arterial pressure in septic shock
por: Yokota, Mari, et al.
Publicado: (2013)

Antithrombin III concentrate therapy may have an efficacy in sepsis
por: Saito, N, et al.
Publicado: (2013)

Relationship between protein C and antithrombin III deficiencies in sepsis without disseminated intravascular coagulation status
por: Takeda, Munekazu, et al.
Publicado: (2008)

Polymyxin B-direct hemoperfusion therapy could contribute to hemodynamics and outcomes in emergency surgical patients
por: Yokota, M, et al.
Publicado: (2012)

Enteral administration of antiepileptic agents could have efficacy for prevention of post-traumatic seizures in severe traumatic brain injury
por: Mocjiduki, K, et al.
Publicado: (2014)

Early diagnosis of sepsis due to Gram-negative infection with the Endotoxin Activity Assay
por: Kang, M, et al.
Publicado: (2014)

Polymyxin B-direct hemoperfusion therapy contributes to oxygen delivery in septic patients
por: Yaguchi, A, et al.
Publicado: (2012)

End-of life thoughts in the ICU: results of a survey
por: Yaguchi, A, et al.
Publicado: (2013)

Endotoxin Activity Assay levels correlate with the microbiological results of Gram-negative organisms in septic patients
por: Tsunoda, M, et al.
Publicado: (2014)

Use of intravenous immunoglobulin to treat sepsis in a general ICU
por: Drakeford, Y, et al.
Publicado: (2015)

What do brain-dead patients ultimately die of?
por: Kawasaki, A, et al.
Publicado: (2014)

Intravenous immunoglobulins prevent breakdown of the blood-brain barrier in experimental sepsis
por: Esen, F, et al.
Publicado: (2010)

Usefulness of intravenous immunoglobulin administration to sepsis-induced coagulopathy in ICU patients
por: Matsumoto, N, et al.
Publicado: (2014)

Effect of intravenous immunoglobulin in critically ill adult patients with sepsis: a meta-analysis
por: Turgeon, A, et al.
Publicado: (2006)

Delirium could be an indicator of sepsis in patients under 65 years old with urinary tract infections
por: Yamada, U, et al.
Publicado: (2012)

Effect of intravenous administration of freeze-dried sulfonated human normal immunoglobulin for septic patients
por: Deguchi, Y, et al.
Publicado: (2009)

Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational study
por: Yaguchi, Arino, et al.
Publicado: (2012)

Low dose immunoglobulin g for treatment of severe sepsis and septic shock
por: Iizuka, Y, et al.
Publicado: (2015)

Intravenous immunoglobulin reduces the ischemia/reperfusion-induced renal injury by increasing insulin-like growth factor-I production in mice
por: Harada, N, et al.
Publicado: (2008)

Sulfonated immunoglobulin improves cardiopulmonary functions by promoting IGF-I production in ARDS patients with severe sepsis
por: Deguchi, Y, et al.
Publicado: (2011)

Immunoglobulin therapy of abdominal sepsis in emergency surgery
por: Butyrsky, O, et al.
Publicado: (2012)

Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
por: Saladi, SM, et al.
Publicado: (2008)

Comparison of the effects of intravenous, enteral and enteral + intravenous supply of glutamine on malnutrition in sepsis
por: Koksal, G, et al.
Publicado: (2011)

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin
por: Kobayashi, T, et al.
Publicado: (2009)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Comparative study between intravenous immunoglobulins and standard treatment in septic patients
por: Hamed, G, et al.
Publicado: (2008)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012)

Background factors in patients receiving immunoglobulin administration and changes in sepsis markers
por: Ikeda, T, et al.
Publicado: (2010)

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone
por: Goto, Masahiro, et al.
Publicado: (2015)

Childhood imported malaria: could we have suppressed risk factors in some children?
por: Pillai, Selva K, et al.
Publicado: (2012)

Low levels of immunoglobulin G in patients with sepsis or septic shock: a signum mali ominis?
por: Dietz, S, et al.
Publicado: (2010)

Effects of intraperitoneal immunoglobulin therapy on behavior and cognitive functions in CLP-induced sepsis model in rats
por: Esen, F, et al.
Publicado: (2013)

Early treatment with intravenous immunoglobulins in patients with critical illness polyneuropathy: a randomized controlled, double-blinded study
por: Brunner, R, et al.
Publicado: (2012)

Could selected probiotics have beneficial effects on clinical outcome of severe traumatic brain injury patients?
por: Pavelescu, D, et al.
Publicado: (2014)

Outcome in severe sepsis and septic shock patients with hematological malignancies: impact of recent intravenous chemotherapeutic treatment
por: Vandijck, D, et al.
Publicado: (2008)

Cerebral autoregulation testing in a porcine model of intravenously administrated E. coli induced fulminant sepsis
por: Molnar, L, et al.
Publicado: (2015)

PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis
por: Kikuchi, M, et al.
Publicado: (2013)

Variations of S-100B in early phases of head trauma
por: Takeda, M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_h35fmqg6t915iohde5omu65pp6